We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan ANDA for Copaxone Accepted by the FDA
Mylan ANDA for Copaxone Accepted by the FDA
September 15, 2009
Mylan’s application for a generic version of Teva Pharmaceutical Industries’ Copaxone multiple sclerosis therapy has been accepted by the FDA.